Programm & Abstracts                 "Innovationen in der Augenheilkunde"

Aktuelle Tagungsinformationen
   News and Updates

Anmeldung zur Tagung
   Registration
Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Collateral Events
Rahmenprogramm
   Social program
Jubiläumsparty
   Jubilee Party
DOG Information
   DOG Information
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Ausstellerliste
   Exhibitors
Sponsoren
   Sponsors
Teilnahmegebühren
   Registration fees
Impressum



DOG Homepage

Influence of Phaco-emulsification with IOL Implantation on IOP and Anti-glaucomatous Therapy of Patients with Open-angle Glaucoma

1Grüb M., 1Mielke J., 1Freudenthaler N., 2Schlote T.,
1Eberhard-Karls-Universität Tübingen, Universitäts-Augenklinik, Abt. I (Tübingen)
2Eberhard-Karls-Universität Tübingen, Universitäts-Augenklinik (Tübingen)

Background: Cataract surgery lowers intraocular pressure (IOP). The question if biometric data have an influence on the pressure lowering effect of phacoemulsification and IOL implantation in patients with open angle glaucoma gave rise to this study.
Patients and methods: 100 phacoemulsifications with IOL implantation in 81 patients (79±8 years; 21m, 60f; 45OD, 55OS) with primary open angle glaucoma were evaluated retrospectively. Groups were created dependent on anterior chamber densitiy (ACD), lens thickness (LT) and axial length (AL) and were correlated with IOP and therapy.
Results: Preoperative IOP was 17,3±3,7mmHg, three months postoperatively 16,2±3,3mmHg (IOP reduction 7,2%, p=0,022). Initial antiglaucomatous therapy was 1,8/day, after three months 1,2/day (reduction 34,7%, p<0,001). There was a statistically significant reduction in IOP and antiglaucomatous therapy independent of ACD, LT or AL, though the clearest reduction was found for ACD <2,5mm (43,9%, p=0,028), LT >5mm (44,6%, p=0,004) and AL <23mm (48,3%, p=0,003).
Conclusions: Phacoemulsification with IOL implantation lowers IOP and antiglaucomatous therapy in patients with open angle glaucoma most for small anterior chamber density, large lens thickness and small axial length.

Zurück/Back